We are live on ! Find out more
APLMW icon

Apollomics Warrant

15 hedge funds and large institutions have $28.8K invested in Apollomics Warrant in 2026 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

7% more funds holding

Funds holding: 14 → 15 (+1)

25% less capital inflows, than outflows

Capital inflows: $2.4K | Capital outflows: $3.21K

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

APLMW Hedge Fund Activity: Q3 2026 in Review

15 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in Apollomics Warrant (APLMW) for Q3 2026, worth a combined $28.8K — down 100% from $7.88M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new APLMW positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 5 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.36K. The largest seller was HRT Financial, cutting an estimated $2.41K.

  • 15 institutional investors held Apollomics Warrant (APLMW) as of Q3 2026, up from 14 in Q2 2026.
  • Funds reported $28.8K of Apollomics Warrant stock for Q3 2026, down 100% quarter-over-quarter.
  • 2 funds opened new Apollomics Warrant positions in Q3 2026 and 1 closed out, a net change of +1 holder.
  • The largest Apollomics Warrant buyer in Q3 2026 was Susquehanna International Group, an estimated $2.36K added.
  • The largest Apollomics Warrant seller in Q3 2026 was HRT Financial, an estimated $2.41K sold.

Based on aggregated 13F filings for Q3 2026.